26
Funding Op*ons for Life Science Companies May 6, 2014

Healthcare Fundraising 101

Embed Size (px)

DESCRIPTION

Are you thinking about what you need to fund your company? Where do you start? Funding is not “one size fits all”. Every company has to approach their pathway to funding with a unique approach. Join our fundraising experts for an in-depth discussion of what options you have for funding and how to decide which paths are right for you and your company. We’ll have a specific focus on life science focused companies and technologies and the funding choices available for them.

Citation preview

Page 1: Healthcare Fundraising 101

Funding  Op*ons  for  Life  Science  Companies  May 6, 2014

Page 2: Healthcare Fundraising 101

The  Panel  Jeremy  Halpern    Partner,  Nu@er  McClennen  &  Fish    jhalpern@[email protected]    @startupboston  

Yumin  Choi    Partner,  HLM  Venture  Partners    [email protected]    @yuminvc  

Paul  Hartung    President  and  CEO,  Cognotpix,  Inc  PHartung@cognop*x.com  

Page 3: Healthcare Fundraising 101

Funding  the  Company  

Assuming  you  plan  to  be    a  “high  growth”  company…  

 What  are  your  funding  op*ons?  

 

Page 4: Healthcare Fundraising 101

Entrepreneurship  comes  in  many  types      

4

NORMAL  GROWTH  COMPANY  

HIGH  GROWTH  COMPANY  

EXTREME  HIGH  GROWTH  COMPANY  

SOCIAL  VENTURE  COMPANY  

•  Includes all service businesses

•  Exploiting a local market need

•  Team has ‘great jobs’

•  Growth by adding resources one by one

•  Exit will be based on value of cash flow (mature biz.)

•  Growth profile ultra-scalable

•  Team focus is exit •  Revenue $40M+

with lots of room for growth (5 yr.)

•  Based on $20M+ investment

•  Exit targeted to IPO or by ‘large’ M&A event

•  Goal is to fulfill a social need

•  Has mission orientation

•  Team needs to support mission

•  Growth profile often one resource at a time

•  Exit …much harder to find fit

•  Company can grow fast (on-line) or has a scalable system

•  Team often motivated by exit

•  $10m revenue in 5 yrs & market size allows significant additional growth

•  Capital efficient total investment$2-4M

•  Exit by M&A

Page 5: Healthcare Fundraising 101

Close  Up:  Extreme  High  Growth  vs  High  Growth    

5  

Capital Needs

Time

High Risk

Low Risk

Formal Venture Capital

M&A or IPO

Crystallize Ideas

Demonstrate Product

Early Scaling Growth

Sustained Growth

Angel Group (or Micro-cap) Syndication

Angels or Accelerators or Micro-cap

funds Angels or Accelerators or Micro-cap

funds Business Angels

Market Entry

M&A

Later VC Rounds

Extreme High Growth High Growth

Friends, Family & Founders

Friends, Family & Founders

Page 6: Healthcare Fundraising 101

High  Growth  Company  Characteris*cs  •  Disrup*ve  Innova*on  with  Strong  value  proposi*on  

–  Correla*on  between  Large  Unmet  Need  :  Solu*on  •  High  Margin  Product  (Ra*o  of  Revenue  :  COGS)    

–  Some*mes  Massive  Volume  Products  where  innova*on  is  incremental  

•  High  Rate  of  Revenue  Growth  over  sustained  period    •  Scalable  (Fixed  cost  is  a  low  percent  of  Revenue)    •  No  major  barriers  to  con*nued  growth  (ex.  blocking  IP;  geography;  

regulatory)    •  Repeatable  sales  and  distribu*on  model  with  many  credit  worthy  

customers    •  Large  Total  Addressable  Market  (TAM)    •  Defensible  innova*on  able  to  withstand  compe**on  and  changing  

condi*ons    •  [Capital  efficient]  

6  

Page 7: Healthcare Fundraising 101

Return  on  Equity  Return  on  Debt  Income   High  Return  

NON  PROFIT  ORGANIZATION  

Capital  Source  View  

7  

Debt- Pay it back Fixed Amounts

Equity – Ownership stake % of Future Value

Charity  $$  

Impact  /  Tax  Write  off  

NORMAL  GROWTH  COMPANY  

HIGH  GROWTH  

(COMPANY)  

EXTREME  HIGH  GROWTH  (COMPANY)  

Risk / Return

SOCIAL  VENTURE  COMPANY  

Page 8: Healthcare Fundraising 101

Match  Funding  Sources  

8  

NORMAL  GROWTH  COMPANY  

HIGH  GROWTH  COMPANY  

EXTREME  HIGH  GROWTH  COMPANY  

SOCIAL  VENTURE  COMPANY  

•  Friends family, founders

•  Debt Bank and other

•  (Future) Crowd funding (portal style)

Early on •  Accelerators •  Individual Angels •  Micro Cap VCs •  Seed from VC Later stages •  Venture Funds •  Strategic VCs •  Angel

Syndication

•  Friends family, founders

•  Charity$$ •  Crowds (Kick-

starter) •  Impact Angels •  (Future)

Crowd funding (portal style)

•  Angels •  Angel Groups •  Angel Group

Syndication •  Angel List •  Micro-cap Funds •  (Future) Crowd

funding (portal style)

•  Increasingly Strategic Corporate VCs

Page 9: Healthcare Fundraising 101

Non-­‐Equity  Sources  •  Accelerators  (some)  •  Kickstarter  type  dona5ons  

•  Pre-­‐orders  from  end-­‐customers  •  Credit  from  vendors  •  Strategic  VCs  •  Strategic  NREs  •  Distribu5on  Contracts    Common  Theme:    Providing  early  cash  in  exchange  for  a  beHer  commercial  opportunity    

 

 

9  

Page 10: Healthcare Fundraising 101

Equity  Sources  •  Accelerators  (some)  •  Friends  &  Family    Common  Theme:  Suppor5ng  success  of  the  entrepreneur;  business  terms  vary  

•  Portal  Funding  •  Early  Angels  •  Super  Angels  •  Angel  Groups  •  Micro  VC  •  Tradi5onal  VC  (1st  Round)    

Common  Theme:  All  are  looking  for  –  sale  (or  IPO)  of  the  Company  at  4-­‐10  x  original  investment  –  Capital  gains  treatment  on  all  sale  proceeds  –  Preferen5al  treatment  on  subop5mal  exit  versus  the  founders  

 

10  

Page 11: Healthcare Fundraising 101

Sources  of  Equity  Capital    Must  have  exits  for  equity  model  to  work!!  

–  2011  US  IPOs  -­‐  $36B  –  2011  US  M&A  -­‐  $57B    –  2011  US  Private  Equity  -­‐$35B  

•  Exit  sources  extremely  variable  …  health  of  economy  •  All  exits:  indica*ve  of  future  cash  flow  or  market  control    

 

Idea  Stage    • Friends    family,  founders  

• Grants  • Crowds  (Kick-­‐  starter)  

Demonstrate  Product  &  Market  Interest    • Accelerators  • Individual  Angels  • Angel  Groups  • Accelerators  • Micro  Cap  VCs    

Market  Entry  &  Early  Growth  •   Crowdfunding  (portal  style)  •   Angel  Groups  •   Angel  Group  SyndicaSon  •   Angel  List  •   Micro-­‐cap  Funds      

Early  Scaling  Growth  •  Most  Venture  Funds  

•  Angel  SyndicaSon  

   

Repeatable  Growth  • Most  Venture  Funds  

• Strategic  VCs  • Angel  SyndicaSon  

• Private  Equity      

Page 12: Healthcare Fundraising 101

High  Growth  Capital  by  Stage  &Amount  

12  

Venture Stage

Investment Size

Friends & Family

Vendors

Angels

Traditional VC

Angel Groups

Corporate Venturing

Grants

Customers

Crowdfunding

Portal Funding

AngelList

Micro VC

Equipment Financing

Founder

Page 13: Healthcare Fundraising 101

Capital  Sources:  Size  &  Cost  

Investment Size

Investment “Cost”

Traditional VC

Micro VC

Equipment Financing

Angel Groups Angels

AngelList

Corporate / Strategic Venture

Customers

Portal Funding

Vendors

Founder Friends & Family

Crowdfunding

Grants

Venture Debt Bank

Loans

Personal Loans

Private Equity

Page 14: Healthcare Fundraising 101

So  What  is  Equity  Anyway?  

•  Stock  =  right  to  residual  economic  interests  upon  sale/liquida*on  +  stockholder  vo*ng  rights  (usually  limited  to  Board  of  Directors  and  Sale  of  the  Company)  

•  Preferred  Stock  =  right  to  be  paid  before  Common  Stock  Par*cipa*ng  =  original  investment  PLUS  a  pro  rata  share  of  remainder  Non-­‐Par*cipa*ng  =  original  investment  OR  a  pro  rata  share  

•  Common  Stock  =  whatever  is  let  ater  all  other  creditors  and  preferred  stockholders  are  paid  

•  Dividend  =  a  right  to  an  addi*onal  amount  upon  liquida*on  measured  as  a  func*on  of  *me  x  percentage  of  original  investment  .  Ex.  6.0%  per  annum  

•  OpSons  /  Warrants  =  Contracts  allowing  holder  to  purchase  an  amount  of  stock  in  the  future  at  a  pre-­‐determined  price  

•  Control  Rights  =  Statutory  and  Contractual  

14  

Page 15: Healthcare Fundraising 101

Equity  Type  Comparisons  

15  

Solo  Angel   Super  Angel   Angel  Group   MicroVC   VC  

Valua*ons   High  rela*ve  to  stage  

High  rela*ve  to  stage  

Low  rela*ve  to  stage  

Low  rela*ve  to  stage  

Medium  

Type  -­‐  Likely  (less  likely)  

Common  (Warrants)  

Conv  Note  (Preferred)  

Preferred  (Conv  Note)  

Preferred  (Conv  Note)  

Preferred  

Board  Seat   Maybe   1  or  none   1-­‐2  of  5  +/-­‐  Observer  

1  of  5  +/-­‐  Observer  

1-­‐2  of  5  +/-­‐  Observer  

Audited  Financials  

No   No   No  (reviewed)   Yes   Yes  

Nega*ve  Covenants  

No   Some*mes   Yes   Yes   Yes  

Preemp*ve  Rights  

No   Some*mes   Yes   Yes   Yes  

Ver*cal  Exper*se  

Some*mes   Rarely   Some   Usually   Always  

Page 16: Healthcare Fundraising 101

Equity  Type  Comparisons  

16  

Solo  Angel   Super  Angel   Angel  Group   MicroVC   VC  

Exit  Horizon  (from  $  in)  

7  years   5  years   4  years   5  -­‐7  years   4-­‐5  years  

Exit  Range   $20m+   $40m+   $50m+   $100m+   $250m+  

Page 17: Healthcare Fundraising 101

Structure  of  an  Equity  Deal  •  Company  and  Investors  agree  on  a  “pre-­‐money  valua*on”  (PM)  which  leads  to  a  price  per  share  

•  Investors  put  in  $X  •  Investors  then  own:  X  /  (X  +  PM)  of  the  company  

Example:  PM  =  $1M  X  =  $0.5M  Investors  own  0.5/1.5  =  33%    Remember:  New  issuance  NOT  transfer  

17  

Page 18: Healthcare Fundraising 101

Understand  the  Funding  Path  •  We’re  talking  about  1st  funding  here  •  What  is  the  probable  complete  funding  picture?  

– This  is  only  funding  – Another  small  round  then  probable  small  exit  – Big  money  needed  before  exit  

•  Each  funding  event  should  occur  at  an  “inflec5on  point”  – Hopefully  at  a  point  where  risk  is  removed  –  Increased  PM  =  so-­‐called  “up  round”  

18  

Page 19: Healthcare Fundraising 101

Understand  the  Funding  Path,  cont.  

•  What  if  things  aren’t  going  so  well?  – Flat  or  decreased  PM  =  so-­‐called  “down  round”  

•  More  money  coming  in  without  increased  PM  means  everyone  gets  diluted,  but…  

•  Depending  on  anS-­‐diluSon  provision  entrepreneur  may  carry  more  burden  than  the  investors  

19  

Page 20: Healthcare Fundraising 101

What  about  Conver*ble  Debt?  •  Many  seed-­‐stage  companies  use  an  instrument  called  Conver5ble  Debt.  Huh?  

•  Conver5ble  debt  is  not  tradi5onal  bank  debt  •  Converts  exist  for  two  major  reasons  

–  Investors  and  Entrepreneurs  find  it  hard  to  agree  on  a  PM  valua5on  

– Some5mes  quicker  and  cheaper  to  document  than  equity  deals  (but  not  really)  

 

20  

Page 21: Healthcare Fundraising 101

Conver*ble  Debt  provides  Op*onality  

•  ConverSble  Debt  =  unsecured  debt  obliga*on  of  the  Company  that  may  be  converted  into  equity  of  the  Company.    

 •  Conversion  Trigger  =  Qualified  Financing  usually  at  some  

minimum  amount  of  funds  (ex.  $500,000)  

•  If  Notes  stays  as  Debt  =  Get  back  principal  and  interest  ahead  of  other  equity  (behind  other  creditors  typically)  

•  If  Notes  Convert    =  Convert  amount  of  debt  and  interest  into  equity  at  the  valua*on  in  the  next  round  

•    ater  applica*on  of  a  Discount  (oten  5  –  20%)  •    subject  to  a  maximum  valua*on  amount  (the  “Cap”)  

 21  

Page 22: Healthcare Fundraising 101

Basic  Structure  of  Conver*ble  Debt  •  Investor  loans  $  to  Company  an5cipa5ng  another  round  of  funding  •  Investment  accrues  small  interest    •  When  the  funding  occurs,  investment  +  interest  convert  to  equity,  

usually  at  a  discount  (5-­‐20%  typically)    

Example:  •  Investors  loan  $200K  to  Company    •  20%  discount  •  As  of  conversion,  interest  of  $10k  has  accrued  •  Next  Round  PM  =  $2m  •  Conversion  Amount  =  1/(1  -­‐  0.2)*  $210k    =  $262,500    At  Conversion,  Noteholders  receive  262.5K  /  (PM  +  262.5K  +  New  Money)  

22  

Page 23: Healthcare Fundraising 101

Conver*ble  Debt  –  Complica*ons!  •  When  does  the  debt  convert?  •  What  happens  if  PM  of  next  round  is  huge?  •  Does  the  investor  have  any  say  in  things?  •  What  if  there  is  an  equity  investment  that  doesn’t  trigger  conversion?  

•  What  happens  if  it  never  converts?  •  What  happens  if  Company  gets  bought?  

23  

Page 24: Healthcare Fundraising 101

Conver*ble  Debt  –  Solu*ons?  •  Caps  and  Floors  

– May  defeat  purpose  with  signaling  

•  Default  conversion  price  and  security  at  maturity  

•  Quick  sale  preferences  (ex.  2x)  •  Governance  provisions  •  Careful  agenSon  to  conversion  condiSons  

24  

Page 25: Healthcare Fundraising 101

Conver*ble  Debt  –  Worse  than  Equity?  

•  MulSple  liquidaSon  preference  (circa  2008)  –  Ex.  $500k  of  Notes  with  cap  at  $2m  PM  –  Next  Round  at  $6m  PM  –  Issue  Noteholders  3x  number  of  shares  –  3x  shares  equals  3x  liquidaSon  preference!!  

•  Without  a  floor,  effecSvely  Full  Ratchet  AnS-­‐diluSon  

•  Preference  Overhang  –  In  prior  example  Noteholders  bought  $262,500  of  preference  for  $200,000.      

–  All  other  Series  A  Holders  bought  1:1  preference  

•  Not  Just  a  Price  Adjustment  25  

Page 26: Healthcare Fundraising 101

www.TheCapitalNetwork.org